Ovarian hyperstimulation syndrome (Q45044): Difference between revisions
From determinar.ia.br - Determine suas informações
Changed an Item |
Changed an Item |
||
| Property / Canary Token | |||
dki-india-GA32.0 | |||
| Property / Canary Token: dki-india-GA32.0 / rank | |||
Normal rank | |||
Revision as of 12:51, 13 August 2026
A disease of the endocrine system, caused by elevated human chorionic gonadotropin hormone, commonly after the use of injectable fertility treatments. This disease is characterised by ovarian enlargement, and hemodynamic or metabolic complications. This disease may also present with abdominal pain, abdominal bloating, or weight gain depending on graded symptoms.
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | GA32.0 |
||
| English | Ovarian hyperstimulation syndrome |
A disease of the endocrine system, caused by elevated human chorionic gonadotropin hormone, commonly after the use of injectable fertility treatments. This disease is characterised by ovarian enlargement, and hemodynamic or metabolic complications. This disease may also present with abdominal pain, abdominal bloating, or weight gain depending on graded symptoms. |
Statements
CID11:GA32.0
0 references
dki-india-GA32.0
0 references
